Serum and Saliva Levels of Ischemia-Modified Albumin in Patients with Acute Myocardial Infarction

Basit Öğe Kaydı
dc.contributor.authorToker, Aysun
dc.contributor.authorAribas, Alpay
dc.contributor.authorYerlikaya, F. Humeyra
dc.contributor.authorTasyurek, Erkan
dc.contributor.authorAkbuga, Kursat
dc.date.accessioned2024-02-23T12:11:10Z
dc.date.available2024-02-23T12:11:10Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.description.abstractObjectiveIschemia-modified albumin (IMA) is a novel marker for diagnosis of myocardial ischemia and it is considered as a serum marker. The aim of the study was to evaluate salivary IMA levels in patients with acute myocardial infarction (AMI) and to determine the relation between serum and salivary IMA levels. MethodsA total of 60 patients with AMI and 40 control subjects who are age and sex matched with AMI group were included in our study. The diagnosis of AMI was based on the WHO classification criteria. All patients underwent the clinical assessment, consisting of electrocardiography, and serum cardiac markers. Serum and salivary IMA levels were measured at the first and second days of AMI by using a colorimetric method. ResultsSerum IMA levels were significantly higher in the first and second day of AMI patients, however, salivary IMA levels were significantly higher in the first day of AMI patients compared to the control (P < 0.05). There was a positive correlation between salivary IMA levels and serum IMA levels both in the first and second day of AMI patients (r = 0.298, P < 0.05; r = 0.319, P < 0.05, respectively). ConclusionWe concluded that salivary IMA levels at the first day of AMI could be used as an alternative marker to serum IMA levels for diagnosis of AMI. J. Clin. Lab. Anal. 27:99-104, 2013. (c) 2013 Wiley Periodicals, Inc.en_US
dc.identifier.doi10.1002/jcla.21569
dc.identifier.endpage104en_US
dc.identifier.issn0887-8013
dc.identifier.issn1098-2825
dc.identifier.issue2en_US
dc.identifier.pmid23400892en_US
dc.identifier.scopus2-s2.0-84875621327en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage99en_US
dc.identifier.urihttps://doi.org/10.1002/jcla.21569
dc.identifier.urihttps://hdl.handle.net/20.500.12452/10576
dc.identifier.volume27en_US
dc.identifier.wosWOS:000329810800003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal Of Clinical Laboratory Analysisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIschemia-Modified Albuminen_US
dc.subjectAcute Myocardial Infarctionen_US
dc.subjectSalivaen_US
dc.titleSerum and Saliva Levels of Ischemia-Modified Albumin in Patients with Acute Myocardial Infarctionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu